Scott D. Sandell

Insider Reports History

Location
Timonium, MD
Signature
/s/ Zachary Bambach, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott D. Sandell:

Form 4 holding 10%+ Owner

Savara Inc

Security class
Common Stock
Shares / value
24,471,264
Estimated value
$108,897,125
Report date
17 Jul 2023
Price
$4.45
Ownership
Indirect
Form 4 holding 10%+ Owner

MBX Biosciences, Inc.

Security class
Common Stock
Shares / value
3,614,486
Estimated value
$38,638,855
Report date
16 Sep 2024
Price
$10.69
Ownership
Indirect
Form 4 holding 10%+ Owner

ARDELYX, INC.

Security class
Common Stock
Shares / value
2,258,850
Estimated value
$14,998,764
Report date
15 Dec 2021
Price
$6.64
Ownership
Indirect
Form 4 holding 10%+ Owner

GLYCOMIMETICS INC

Security class
Common Stock
Shares / value
2,237,196
Estimated value
$5,279,783
Report date
26 Jan 2023
Price
$2.36
Ownership
Indirect
Form 4 holding 10%+ Owner

Metacrine, Inc.

Security class
Common Stock
Shares / value
2,563,257
Estimated value
$1,204,731
Report date
22 Dec 2021
Price
$0.4700
Ownership
Indirect
Form 4 holding Director

Bloom Energy Corp

Security class
Class A Common Stock
Shares / value
55,751
Estimated value
$684,065
Report date
31 Mar 2022
Price
$12.27
Ownership
Direct
Form 4 holding 10%+ Owner

Sagimet Biosciences Inc.

Security class
Series A Common Stock
Shares / value
6,997
Estimated value
$28,688
Report date
29 Jan 2024
Price
$4.10
Ownership
Indirect
Form 4 holding 10%+ Owner

IonQ, Inc.

Security class
Common Stock
Shares / value
1,141
Estimated value
$15,076
Report date
16 Nov 2022
Price
$13.21
Ownership
Indirect
Form 4 holding 10%+ Owner

Eargo, Inc.

Security class
Common Stock
Shares / value
1,231
Estimated value
$3,188
Report date
24 May 2021
Price
$2.59
Ownership
Indirect
Form 4 holding 10%+ Owner

Desktop Metal, Inc.

Security class
Class A Common Stock
Shares / value
878
Estimated value
$644
Report date
08 Jun 2021
Price
$0.7332
Ownership
Indirect
Form 4 holding 10%+ Owner

Korro Bio, Inc.

Security class
Pre-Funded Warrants
Shares / value
242,945
Estimated value
Report date
10 Mar 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Akouos, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
30 Nov 2022
Price
$12.50
Ownership
Indirect
Form 4 holding 10%+ Owner

Arcellx, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
23 Dec 2022
Price
$55.27
Ownership
Indirect
Form 4 holding 10%+ Owner

MBX Biosciences, Inc.

Security class
Series A Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
16 Sep 2024
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

MBX Biosciences, Inc.

Security class
Series B Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
16 Sep 2024
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Monte Rosa Therapeutics, Inc.

Security class
Series A-2 convertible preferred stock
Shares / value
0
Estimated value
Report date
28 Jun 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Monte Rosa Therapeutics, Inc.

Security class
Series B convertible preferred stock
Shares / value
0
Estimated value
Report date
28 Jun 2021
Price
$2.00
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Monte Rosa Therapeutics, Inc.

Security class
Series C convertible preferred Stock
Shares / value
0
Estimated value
Report date
28 Jun 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

NeueHealth, Inc.

Security class
Series A Convertible Perpetual Preferred Stock
Shares / value
0
Estimated value
Report date
02 Oct 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

NeueHealth, Inc.

Security class
Series B Convertible Perpetual Preferred Stock
Shares / value
0
Estimated value
Report date
02 Oct 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

NeueHealth, Inc.

Security class
Warrant (Right to Buy)
Shares / value
0
Estimated value
Report date
02 Oct 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Robinhood Markets, Inc.

Security class
Class A Common Stock
Shares / value
0
Estimated value
Report date
12 May 2022
Price
$12.28
Ownership
Indirect
Form 4 holding 10%+ Owner

SpyGlass Pharma, Inc.

Security class
Series C-1 Preferred Stock
Shares / value
0
Estimated value
Report date
09 Feb 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

SpyGlass Pharma, Inc.

Security class
Series C-2 Preferred Stock
Shares / value
0
Estimated value
Report date
09 Feb 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Scott D. Sandell

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .